Do you want to visit this external website and leave amgenpro.com.au?
You are now leaving this Amgen Australia website. Amgen Australia assumes no responsibility for, and exercises no control over, the organizations, opinions, or accuracy of the information on the server or website you are redirected to.
Do you want to visit this external website and leave amgenpro.com.au?
You are now leaving this Amgen Australia website. Amgen Australia assumes no responsibility for, and exercises no control over, the organizations, opinions, or accuracy of the information on the server or website you are redirected to.
You can paste this link into an email or message to share this resource with your patient.
Overview ARANESP® (darbepoetin alfa)
Aranesp® (darbepoetin)
Aranesp contains the active ingredient darbepoetin alfa. Aranesp is used to treat anaemia that is associated with chronic renal failure (kidney failure) and in patients with non-myeloid cancers where anaemia develops as a result of chemotherapy.
AmgenPro is intended for healthcare professionals in Australia
Login or create an AmgenPro account to access the latest updates on our products, medical resources and patient programs.
